Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability

NCT07239414 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

690

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular

Interventions

DRUG: Bempedoic Acid 180 MG Oral Tablet
DRUG: Rosuvastatin 5 mg
DRUG: Placebo

Sponsor

Sohaib Ashraf